Skip to main content
Clinical Trials/NCT06458387
NCT06458387
Not yet recruiting
Not Applicable

Comparison of Clinical Outcomes According to High-protein Provision Through Parenteral Nutrition in Critically Ill Patients Immediately After Abdominal Surgery: a Prospective, Single-blinded, Randomized Controlled Trial

Seoul St. Mary's Hospital1 site in 1 country152 target enrollmentJuly 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Protein Malnutrition
Sponsor
Seoul St. Mary's Hospital
Enrollment
152
Locations
1
Primary Endpoint
6-month mortality rate
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Protein malnutrition in critically ill patients is a global concern due to its association with prolonged hospital stays, and higher morbidity rates. Patients who undergo abdominal surgery are particularly vulnerable due to alterations in gastrointestinal function and prolonged fasting. Despite the significance of proper nutrition, the optimal target of protein supplementation remains controversial.

The investigators aimed to evaluate the effects of high protein provision, targeting a protein intake of at least 1.5 g/kg/day for the first 3 days after abdominal surgery, on 6-month mortality.

Detailed Description

During the acute phase of critical illness, patients experience metabolic and physiological changes that affects their nutrition status. One prominent feature is the activation of stress hormones and inflammatory mediators, which contribute to a negative nitrogen balance, increased gluconeogenesis, and accelerated muscle proteolysis. Among these patients, those who undergo abdominal surgery are particularly vulnerable to malnutrition as they experience alterations in the structural barrier of the gastrointestinal tract, impaired nutrient absorption, and prolonged fasting due to concerns such as the integrity of an anastomosis. Thus, appropriate protein provision should be prioritized for critically ill patients following abdominal surgery, and it should include adequate nutritional support to preserve lean body mass and organ function. Despite the importance of nutritional supply, the recommendations for protein vary according to different guidelines, and this is the same for surgical patients. Recent randomized controlled trials reported conflicting results with current guidelines, with some suggesting that higher protein dose administrations did not significantly impact clinical outcomes and may even worsen the outcomes for certain patient groups. Thus, the optimal protein provision target during the acute phase of critical illness, particularly for surgical patients, remains controversial. The investigators aimed to assess the effects of strict high protein provision between the high protein group (protein target supplemented with 1.5 g/kg/day) and the control group (protein target supplemented with less than 1.5 g/kg/day) using intravenous nutrient solution for the first 3 days after abdominal surgery. Additionally, the investigators investigated the appropriate target for protein provision in critically ill patients who undergo abdominal surgery.

Registry
clinicaltrials.gov
Start Date
July 2024
End Date
June 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eun Young Kim

Professor

Seoul St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients admitted after abdominal surgery to our institution's surgical ICU
  • They were enrolled regardless of the surgical method, either open, laparoscopy, or robotic.

Exclusion Criteria

  • aged under 18 years
  • underwent surgery under local or regional anesthesia
  • readmitted to the ICU due to any cause
  • diagnosed with renal failure and receiving renal replacement therapy
  • patients diagnosed with multiorgan failure, represented by a high Sequential Organ Failure Assessment (SOFA) score (≥9) upon ICU admission
  • failed to provide informed consent, or with 'do-not-resuscitate' status.

Outcomes

Primary Outcomes

6-month mortality rate

Time Frame: Participants were followed up to 180 days immediately after the surgery

Proportion of patients who died within 6 months after surgery among participants

Secondary Outcomes

  • 30-day mortality rate(Participants were followed up to 30 days immediately after the surgery)
  • 90-day mortality rate(Participants were followed up to 90 days immediately after the surgery)
  • Incidence of postoperative complications(Participants were followed during hospitalization (up to 14 days))

Study Sites (1)

Loading locations...

Similar Trials